What is the role of monitoring antiretroviral therapy (ART) progress pediatric HIV infection?

Updated: Mar 05, 2020
  • Author: Delia M Rivera, MD; Chief Editor: Russell W Steele, MD  more...
  • Print

Close monitoring to determine whether the child is tolerating ART and to answer any questions the caregiver may have are essential to the success of these therapies. At 4-8 weeks after the start of therapy, the CD4+ count and/or percentage and HIV RNA levels should be reassessed, and laboratory evaluations for toxicity should be done.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!